Aanderud S, Aarbakke J, Sundsfjord J
Horm Metab Res. 1986 Feb;18(2):110-3. doi: 10.1055/s-2007-1012244.
The in vitro effect of various selective and non-selective beta-blocking drugs and adrenaline on the conversion of thyroxine (T4) to triiodothyronine (T3) was studied in suspensions of isolated rat hepatocytes after 90 min of incubation. Compared with the untreated controls propranolol caused a dose-related inhibition of the T4 to T3 conversion in conc of 100, 200 and 400 microM. The other beta-blocking drugs studied, timolol, oxprenolol, atenolol and metoprolol, were without any effect on this in vitro conversion. Propranolol did not interfere with the cellular association of T4 or the degradation of T4 and T3. Adrenaline 200 microM caused a small decrease of T3 in the medium and a corresponding increase in the intracellular content of T3. The inhibitory effect of propranolol 200 microM was not antagonized by equimolar concentrations of adrenaline. Our study suggests that the inhibitory effect of propranolol on the conversion of T4 to T3 in hepatocytes is caused by a direct chemical effect of the drug unrelated to its beta-blocking and membrane stabilizing properties.
在离体大鼠肝细胞悬液中孵育90分钟后,研究了各种选择性和非选择性β受体阻滞剂及肾上腺素对甲状腺素(T4)向三碘甲状腺原氨酸(T3)转化的体外作用。与未处理的对照组相比,普萘洛尔在浓度为100、200和400微摩尔时,对T4向T3的转化产生剂量相关的抑制作用。所研究的其他β受体阻滞剂,噻吗洛尔、氧烯洛尔、阿替洛尔和美托洛尔,对这种体外转化没有任何影响。普萘洛尔不干扰T4的细胞结合或T4和T3的降解。200微摩尔的肾上腺素使培养基中的T3略有下降,细胞内T3含量相应增加。200微摩尔普萘洛尔的抑制作用未被等摩尔浓度的肾上腺素拮抗。我们的研究表明,普萘洛尔对肝细胞中T4向T3转化的抑制作用是由该药物的直接化学作用引起的,与其β受体阻滞和膜稳定特性无关。